Role of CaMKII in Ang-II-dependent small artery remodeling

Vascular Pharmacology

Volumn 87, Issue , 2016, Pages 172-179

  Prasad, Anand M ^a   Ketsawatsomkron, Pimonrat ^a   Nuno, Daniel W ^a   Koval, Olha M ^a   Dibbern, Megan E ^a   Venema, Ashlee N ^a   Sigmund, Curt D ^a   Lamping, Kathryn G ^a,b   Grumbach, Isabella M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b Iowa City VA Health Care System   (United States)

Author keywords

Ang II; CaMKII; Remodeling; Smooth muscle

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II GAMMA; CALPONIN; CYCLIN E; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOCARDIN; MYOSIN HEAVY CHAIN 11; MYOSIN HEAVY CHAIN 9; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; PHENYLEPHRINE; PHOSPHOLAMBAN; POTASSIUM CHLORIDE; SEROTONIN; SERUM RESPONSE FACTOR; STRUCTURAL PROTEIN; TROPOMYOSIN; UNCLASSIFIED DRUG; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BLOOD VESSEL WALL; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; IMMUNOBLOTTING; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMALL ARTERY REMODELING; SMOOTH MUSCLE CELL; VASCULAR REMODELING; VASOCONSTRICTION; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; FEMALE; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RNA, MESSENGER; VASCULAR REMODELING; VASOCONSTRICTION;

EID: 84999885129     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2016.09.007     Document Type: Article

References (48)

1. [1] Mulvany, M.J., Small artery remodeling in hypertension. Curr. Hypertens. Rep. 4 (2002), 49–55.
2. [2] Aalkjaer, C., Heagerty, A.M., Petersen, K.K., Swales, J.D., Mulvany, M.J., Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation–contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 61 (1987), 181–186.
3. [3] Schiffrin, E.L., Deng, L.Y., Larochelle, P., Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J. Hypertens. 10 (1992), 437–444.
4. [4] Moreau, P., d'Uscio, L.V., Shaw, S., Takase, H., Barton, M., Luscher, T.F., Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. Circulation 96 (1997), 1593–1597.
5. [5] Parker, S.B., Wade, S.S., Prewitt, R.L., Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression. Hypertension 32 (1998), 452–458.
6. [6] Rizzoni, D., Porteri, E., Boari, G.E., De Ciuceis, C., Sleiman, I., Muiesan, M.L., Castellano, M., Miclini, M., Agabiti-Rosei, E., Prognostic significance of small-artery structure in hypertension. Circulation 108 (2003), 2230–2235.
7. [7] Neves, M.F., Virdis, A., Schiffrin, E.L., Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. J. Hypertens. 21 (2003), 189–198.
8. [8] Thybo, N.K., Stephens, N., Cooper, A., Aalkjaer, C., Heagerty, A.M., Mulvany, M.J., Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 25 (1995), 474–481.
9. [9] Schiffrin, E.L., Deng, L.Y., Larochelle, P., Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 23 (1994), 83–91.
10. [10] Christensen, K.L., Mulvany, M.J., Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J. Hypertens. 19 (2001), 1001–1006.
11. [11] Erickson, J.R., He, B.J., Grumbach, I.M., Anderson, M.E., CaMKII in the cardiovascular system: sensing redox states. Physiol. Rev. 91 (2011), 889–915.
12. 2 + dependence for activation of Ca2 +/calmodulin-dependent protein kinase II in vascular smooth muscle cells. J. Biol. Chem. 271 (1996), 2506–2513.
13. [13] Mortality after 10 1/2 years for hypertensive participants in the multiple risk factor intervention trial. Circulation, 82, 1990, 1616–1628.
14. 2 +/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ. Res. 81 (1997), 575–584.
15. [15] Fluck, M., Booth, F.W., Waxham, M.N., Skeletal muscle CaMKII enriches in nuclei and phosphorylates myogenic factor SRF at multiple sites. Biochem. Biophys. Res. Commun. 270 (2000), 488–494.
16. [16] Lamping, K.G., Faraci, F.M., Role of sex differences and effects of endothelial NO synthase deficiency in responses of carotid arteries to serotonin. Arterioscler. Thromb. Vasc. Biol. 21 (2001), 523–528.
17. [17] Min, L.J., Mogi, M., Tamura, K., Iwanami, J., Sakata, A., Fujita, T., Tsukuda, K., Jing, F., Iwai, M., Horiuchi, M., Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway. J. Mol. Cell. Cardiol. 47 (2009), 798–809.
18. [18] Minami, K., Fukuzawa, K., Nakaya, Y., Protein kinase C inhibits the Ca(2 +)-activated K + channel of cultured porcine coronary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 190 (1993), 263–269.
19. 2 +/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21. J. Biol. Chem. 286 (2011), 7990–7999.
20. [20] Scott, J.A., Klutho, P.J., El Accaoui, R., Nguyen, E., Venema, A.N., Xie, L., Jiang, S., Dibbern, M., Scroggins, S., Prasad, A.M., Luczak, E.D., Davis, M.K., Li, W., Guan, X., Backs, J., Schlueter, A.J., Weiss, R.M., Miller, F.J., Anderson, M.E., Grumbach, I.M., The multifunctional Ca(2 +)/calmodulin-dependent kinase IIdelta (CaMKIIdelta) regulates arteriogenesis in a mouse model of flow-mediated remodeling. PLoS One, 8, 2013, e71550.
21. 2 +/calmodulin-dependent protein kinase II-gamma (CaMKIIgamma) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling. FASEB J. 30 (2016), 1051–1064.
22. 2 +/calmodulin-dependent kinase II. Hypertension 62 (2013), 434–441.
23. [23] Prasad, A.M., Morgan, D.A., Nuno, D.W., Ketsawatsomkron, P., Bair, T.B., Venema, A.N., Dibbern, M.E., Kutschke, W.J., Weiss, R.M., Lamping, K.G., Chapleau, M.W., Sigmund, C.D., Rahmouni, K., Grumbach, I.M., Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function. J. Am. Heart Assoc., 4, 2015.
24. [24] Folkow, B., Physiological aspects of primary hypertension. Physiol. Rev. 62 (1982), 347–504.
25. [25] Li, L., Feng, D., Luo, Z., Welch, W.J., Wilcox, C.S., Lai, E.Y., Remodeling of afferent arterioles from mice with oxidative stress does not account for increased contractility but does limit excessive wall stress. Hypertension 66 (2015), 550–556.
26. [26] King, A.J., Osborn, J.W., Fink, G.D., Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50 (2007), 547–556.
27. [27] Boucher, P., Gotthardt, M., Li, W.P., Anderson, R.G., Herz, J., LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300 (2003), 329–332.
28. [28] Zhang, R., Khoo, M.S., Wu, Y., Yang, Y., Grueter, C.E., Ni, G., Price, E.E. Jr., Thiel, W., Guatimosim, S., Song, L.S., Madu, E.C., Shah, A.N., Vishnivetskaya, T.A., Atkinson, J.B., Gurevich, V.V., Salama, G., Lederer, W.J., Colbran, R.J., Anderson, M.E., Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11 (2005), 409–417.
29. [29] Bader, H., Dependence of wall stress in the human thoracic aorta on age and pressure. Circ. Res. 20 (1967), 354–361.
30. [30] Lamping, K., Faraci, F., Enhanced vasoconstrictor responses in eNOS deficient mice. Nitric Oxide Biol. Chem. 8 (2003), 207–213.
31. [31] Wang, D., Chang, P.S., Wang, Z., Sutherland, L., Richardson, J.A., Small, E., Krieg, P.A., Olson, E.N., Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105 (2001), 851–862.
32. [32] Mattiazzi, A., Vittone, L., Mundina-Weilenmann, C., Said, M., Phosphorylation of the Thr17 residue of phospholamban. New insights into the physiological role of the CaMK-II pathway of phospholamban phosphorylation. Ann. N. Y. Acad. Sci. 853 (1998), 280–283.
33. 2 + desensitization. Mol. Cell. Biochem. 127–128 (1993), 229–237.
34. 2 + sensitivity of light chain phosphorylation within smooth muscle cells. J. Biol. Chem. 269 (1994), 9912–9920.
35. [35] Tansey, M.G., Word, R.A., Hidaka, H., Singer, H.A., Schworer, C.M., Kamm, K.E., Stull, J.T., Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle cells. J. Biol. Chem. 267 (1992), 12511–12516.
36. [36] Sparks, M.A., Parsons, K.K., Stegbauer, J., Gurley, S.B., Vivekanandan-Giri, A., Fortner, C.N., Snouwaert, J., Raasch, E.W., Griffiths, R.C., Haystead, T.A., Le, T.H., Pennathur, S., Koller, B., Coffman, T.M., Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension 57 (2011), 577–585.
37. [37] Li, H., Li, W., Gupta, A.K., Mohler, P.J., Anderson, M.E., Grumbach, I.M., Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 298 (2010), H688–H698.
38. [38] MacDonnell, S.M., Weisser-Thomas, J., Kubo, H., Hanscome, M., Liu, Q., Jaleel, N., Berretta, R., Chen, X., Brown, J.H., Sabri, A.K., Molkentin, J.D., Houser, S.R., CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. Circ. Res. 105 (2009), 316–325.
39. [39] Liu, Y., Sun, L.Y., Singer, D.V., Ginnan, R., Singer, H.A., CaMKIIdelta-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscle. J. Biol. Chem. 288 (2013), 33519–33529.
40. [40] Folkow, B., “Structural factor” in primary and secondary hypertension. Hypertension 16 (1990), 89–101.
41. 2 + influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 15623–15628.
42. [42] Suzuki, E., Nishimatsu, H., Satonaka, H., Walsh, K., Goto, A., Omata, M., Fujita, T., Nagai, R., Hirata, Y., Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes. Circ. Res. 90 (2002), 1004–1011.
43. [43] Wada, H., Hasegawa, K., Morimoto, T., Kakita, T., Yanazume, T., Abe, M., Sasayama, S., Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J. Cell Biol. 156 (2002), 983–991.
44. [44] Davis, F.J., Gupta, M., Camoretti-Mercado, B., Schwartz, R.J., Gupta, M.P., Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J. Biol. Chem. 278 (2003), 20047–20058.
45. [45] Atkins, C.M., Nozaki, N., Shigeri, Y., Soderling, T.R., Cytoplasmic polyadenylation element binding protein-dependent protein synthesis is regulated by calcium/calmodulin-dependent protein kinase II. J. Neurosci. Off. J. Soc. Neurosci. 24 (2004), 5193–5201.
46. [46] Staiculescu, M.C., Galinanes, E.L., Zhao, G., Ulloa, U., Jin, M., Beig, M.I., Meininger, G.A., Martinez-Lemus, L.A., Prolonged vasoconstriction of resistance arteries involves vascular smooth muscle actin polymerization leading to inward remodelling. Cardiovasc. Res. 98 (2013), 428–436.
47. [47] Pang, J., Yan, C., Natarajan, K., Cavet, M.E., Massett, M.P., Yin, G., Berk, B.C., GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 892–898.
48. [48] House, S.J., Ginnan, R.G., Armstrong, S.E., Singer, H.A., Calcium/calmodulin-dependent protein kinase II-delta isoform regulation of vascular smooth muscle cell proliferation. Am. J. Phys. Cell Physiol. 292 (2007), C2276–C2287.